Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-13T22:35:04.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid in AMD and DME patients, as well as the evaluation of patient experience when using the Notal-OCT V2.5 device.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:37.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a detailed explanation of eligibility criteria, including examples such as general health condition or prior treatments. Additionally, specific inclusion criteria for the study have been outlined, such as the ability to give informed consent and a diagnosis of AMD or DME.
    Difference
    12%
    Check dated 2024-05-22T21:17:08.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:39:08.000Z thumbnail image

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.